Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1972 1
1977 1
1978 1
1980 1
1981 2
1982 1
1985 1
1986 1
1987 3
1988 1
1989 10
1990 6
1991 12
1992 9
1993 11
1994 9
1995 6
1996 6
1997 3
1998 3
1999 7
2000 10
2001 7
2002 2
2003 2
2004 6
2005 6
2006 2
2007 4
2008 6
2009 7
2010 4
2011 5
2012 4
2013 4
2014 6
2015 9
2016 9
2017 7
2018 13
2019 13
2020 5
2021 8
2022 9
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.
Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T. Cook LB, et al. Among authors: ratner l. J Clin Oncol. 2019 Mar 10;37(8):677-687. doi: 10.1200/JCO.18.00501. Epub 2019 Jan 18. J Clin Oncol. 2019. PMID: 30657736 Free PMC article.
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.
Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, Barta S, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Chadburn A, Cruz M, Dittmer DP, Dyer MA, Farinha P, Gastier-Foster JM, Gerrie AS, Grande BM, Greiner T, Griner NB, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi R, Leal FE, Lee MS, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack G, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson WH, Wong J, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD. Thomas N, et al. Among authors: ratner l. Blood. 2023 Feb 23;141(8):904-916. doi: 10.1182/blood.2022016534. Blood. 2023. PMID: 36201743 Free PMC article.
A role for an HTLV-1 vaccine?
Ratner L. Ratner L. Front Immunol. 2022 Sep 8;13:953650. doi: 10.3389/fimmu.2022.953650. eCollection 2022. Front Immunol. 2022. PMID: 36159878 Free PMC article. Review.
Adult T-Cell Leukemia/Lymphoma.
Mehta-Shah N, Ratner L, Horwitz SM. Mehta-Shah N, et al. Among authors: ratner l. J Oncol Pract. 2017 Aug;13(8):487-492. doi: 10.1200/JOP.2017.021907. J Oncol Pract. 2017. PMID: 28796966 Free PMC article. Review.
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Rubinstein PG, Moore PC, Bimali M, Lee JY, Rudek MA, Chadburn A, Ratner L, Henry DH, Cesarman E, DeMarco CE, Costagliola D, Taoufik Y, Ramos JC, Sharon E, Reid EG, Ambinder RF, Mitsuyasu R, Mounier N, Besson C, Noy A; AIDS Malignancy Consortium; Lymphoma Study Association. Rubinstein PG, et al. Among authors: ratner l. Lancet Haematol. 2023 Aug;10(8):e624-e632. doi: 10.1016/S2352-3026(23)00157-6. Lancet Haematol. 2023. PMID: 37532416 Clinical Trial.
Upcoming 5-year data will evaluate the sustainability of the outcomes obtained. FUNDING: National Institutes of Health and National Cancer Institute....
Upcoming 5-year data will evaluate the sustainability of the outcomes obtained. FUNDING: National Institutes of Health and National Cance …
Human T-cell leukemia virus-associated malignancy.
Panfil AR, Martinez MP, Ratner L, Green PL. Panfil AR, et al. Among authors: ratner l. Curr Opin Virol. 2016 Oct;20:40-46. doi: 10.1016/j.coviro.2016.08.009. Epub 2016 Aug 31. Curr Opin Virol. 2016. PMID: 27591679 Free PMC article. Review.
Molecular biology of human T cell leukemia virus.
Ratner L. Ratner L. Semin Diagn Pathol. 2020 Mar;37(2):104-109. doi: 10.1053/j.semdp.2019.04.003. Epub 2019 Apr 16. Semin Diagn Pathol. 2020. PMID: 31103249 Free PMC article. Review.
Nef.
Ratner L, Niederman TM. Ratner L, et al. Curr Top Microbiol Immunol. 1995;193:169-208. doi: 10.1007/978-3-642-78929-8_10. Curr Top Microbiol Immunol. 1995. PMID: 7648875 Review. No abstract available.
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.
Wang-Gillam A, Lim KH, McWilliams R, Suresh R, Lockhart AC, Brown A, Breden M, Belle JI, Herndon J, Bogner SJ, Pedersen K, Tan B, Boice N, Acharya A, Abdiannia M, Gao F, Yoon HH, Zhu M, Trikalinos NA, Ratner L, Aranha O, Hawkins WG, Herzog BH, DeNardo DG. Wang-Gillam A, et al. Among authors: ratner l. Clin Cancer Res. 2022 Dec 15;28(24):5254-5262. doi: 10.1158/1078-0432.CCR-22-0308. Clin Cancer Res. 2022. PMID: 36228156 Free PMC article. Clinical Trial.
241 results